On 31 May 2017, the Immuno Valley Annual Conference will take place in Utrecht, the Netherlands. The theme of this edition of the annual science & business partnering event will be:

Partnerships in infectious disease prevention

The program will start at 11:00 with the first keynote speakers. However, from 10:00-11:00 you are invited to join a 1-1 partnering meeting. Find the complete program here (pdf).

Keynote speakers

We have invited excellent speakers from industry and science to present their work to you during the day. You will find their profiles here.

Pitch session

Immuno Valley network partners will present a pitch during the Immuno Valley Annual Conference. A variety of subjects in infectious disease prevention in humans and animals will be presented. Read more about the pitch session and the presenting partners here.


As a network organization, Immuno Valley values both networking opportunities and 1-to-1 meetings: throughout the day, you will find these in the program

These organisations are already registered to attend the Immuno Valley Annual Conference 2017:

Abera Bioscience, AIGHD, Almare Consultancy, BioClin, Dopharma, Epivax, Flanders Vaccine, Ghent University, GSK, HU University of Applied Sciences Utrecht, Intravacc, Janssen Vaccines & Prevention BV, Leiden University Medical Centre, Maastricht University, NIZO, Nutrileads, Perstorp, Pulike Biological Engineering, RA Consultancy, Radboudumc, Sanquin, SGS Life Science services , Thermo Fisher Scientific | Prionics Lelystad BV, TNO, TU Eindhoven, UMC Utrecht, Utrecht University, Vetoquinol, ViroVET, Vrije Universiteit Amsterdam, Wageningen Bioveterinary Research, Wageningen University and Zoetis

Register Now!

Date: 31 May 2017
Time: 10:00-18:30 hrs
Location: Hotel Mitland, Ariënslaan 1, Utrecht, The Netherlands

Register now!

Program overview


Registration with coffee
Location: Lounge

1 to 1 Meetings
Vijverzaal / lounge


Opening by chairman   


Immuno Valley update
Liana Steeghs, managing director Immuno Valley



“Launch of Bac-Vactory program”
 Prof Dr. Jan Tommassen, Utrecht University, Program leader Bac –Vactory



“Rational Vaccine Design”    
Dr. Mahesh Kumar, Vice President, Global Biologics R&D, Global Diagnostics R&D
at Zoetis Inc.


Lunch break
Location: Lounge

1 to 1 Meetings
Vijverzaal / Lounge

Immuno Valley Partner Council (Partner Council members only)
Location: room Berk & Hazelaar

13:30-14:00 "Use of validated, dynamic in vitro models of the GI tract to combat infectious diseases, develop alternatives for antibiotics, and prevent (multiple) antibiotic resistance of members of the gut microbiota" 
Prof. Dr. Koen Venema, Maastricht University


14:00-14:15 "Microbiome and causality: the relation between ichthyosis vulgaris, host genotype and skin microbiota"
Sacha van Hijum, NIZO 
14:15-14:30 “Two-dimensional cultured intestinal stem-cell derived organoids as a model for intestinal permeability and transport”
Stefan Vaessen , University of Technology Utrecht    


“Microbiome in health and disease
Frank Schuren, TNO      
14:45-15:00 “Novel therapeutic antimicrobial peptides to treat bacterial infections in patients with cystic fibrosis”
Martin van Eijk, Utrecht University
15:00-15:15 Coffee break
Location: Lounge
 15:15-15:45 "The microbiome and response to vaccination"           
Dr. Vanessa Harris, Amsterdam Institute for Global Health and Development (AIGHD) 


 15:45-16:00 “SGS Life Science services in challenge studies”
Bruno Speder , SGS Life Science      
 16:00-16:15  “Sanquin’s immunomonitoring technology”                    
Anja ten Brinke, Sanquin 
 16:15-16:30 R&D at Pulike Biological Engineering”
Pieter Brouwer, Pulike      

“Swine Influenza Epitope Validation” 
Oreda Boussadia, EpiVax

16:45-17:15 ”Novel approaches to bacterial vaccine development”          
Mariagrazia Pizza, GSK    
17:15-17:20 Immuno Valley Award Ceremony
Liana Steeghs, managing director Immuno Valley

Closing words


Drinks and bites
Location: Lounge


Find the complete program here (pdf).